Table 3 describes the association between CA 15-3 levels (classified as negative or positive) and the corresponding levels of CA125, CEA, AFP, fT4, and TSH among cases diagnosed with breast cancer in the observed cohort. This evidence concerns the gene CEACAM5 and breast cancer.